BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 21428773)

  • 21. [Debates surrounding COPD].
    Tillie-Leblond I; Housset B
    Rev Mal Respir; 2010 Feb; 27(2):106-7. PubMed ID: 20206057
    [No Abstract]   [Full Text] [Related]  

  • 22. Uplifting times for COPD.
    Halpin DM
    Prim Care Respir J; 2008 Dec; 17(4):197-8. PubMed ID: 18972060
    [No Abstract]   [Full Text] [Related]  

  • 23. Anticholinergic agents in asthma and COPD.
    Gross NJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):36-9. PubMed ID: 16488410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New cholinergic drugs in asthma and COPD].
    Kuś J
    Pneumonol Alergol Pol; 2002; 70 Suppl 1():61-3. PubMed ID: 12518641
    [No Abstract]   [Full Text] [Related]  

  • 25. A study to assess COPD Symptom-based Management and to Optimise treatment Strategy in Japan (COSMOS-J) based on GOLD 2011.
    Betsuyaku T; Kato M; Fujimoto K; Hagan G; Kobayashi A; Hitosugi H; James M; Jones PW
    Int J Chron Obstruct Pulmon Dis; 2013; 8():453-9. PubMed ID: 24124358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultra-LAMA, ultra-LABA, ultra-inhaled steroids? The future has landed.
    Domingo C
    Arch Bronconeumol; 2013 Apr; 49(4):131-4. PubMed ID: 23415574
    [No Abstract]   [Full Text] [Related]  

  • 27. Albuterol and levalbuterol use and spending in Medicare beneficiaries with chronic obstructive pulmonary disease.
    Puig A; McElligott S; Bergquist H; Doshi JA
    Am J Geriatr Pharmacother; 2010 Dec; 8(6):571-82. PubMed ID: 21356506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.
    Somand H; Remington TL
    Ann Pharmacother; 2005 Sep; 39(9):1467-75. PubMed ID: 16030078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology.
    Seemungal T; Stockley R; Calverley P; Hagan G; Wedzicha JA
    COPD; 2007 Sep; 4(3):177-83. PubMed ID: 17729060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial].
    Fang LZ; Liang X; Zhang JQ; Liu L; Fu WP; Zhao ZH; Dai LM
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):811-4. PubMed ID: 19080533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rebuttal: should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? Yes.
    Salpeter SR
    Can Fam Physician; 2007 Sep; 53(9):1429-30, 1432-3. PubMed ID: 17872865
    [No Abstract]   [Full Text] [Related]  

  • 32. [New COPD guideline. Physical training pays].
    Spielmanns M
    MMW Fortschr Med; 2007 Sep; 149(35-36):10. PubMed ID: 17948374
    [No Abstract]   [Full Text] [Related]  

  • 33. New therapy for managing moderate to severe chronic obstructive pulmonary disease.
    Chou A; D'Urzo AD
    Can Fam Physician; 2014 Apr; 60(4):352-4. PubMed ID: 24733327
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of tiotropium and other long acting bronchodilators in chronic obstructive pulmonary disease.
    Currie GP; Rossiter C; Miles SA; Lee DK; Dempsey OJ
    Pulm Pharmacol Ther; 2006; 19(2):112-9. PubMed ID: 15970450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta2-adrenergic receptor polymorphisms as a determinant of preferential bronchodilator responses to β2-agonist and anticholinergic agents in Japanese patients with chronic obstructive pulmonary disease.
    Konno S; Makita H; Hasegawa M; Nasuhara Y; Nagai K; Betsuyaku T; Hizawa N; Nishimura M
    Pharmacogenet Genomics; 2011 Nov; 21(11):687-93. PubMed ID: 21881540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tiotropium bromide (Spiriva) in stablechronic obstructive pulmonary disease].
    Lobzhanidze TV; Sikharulidze LP; Kurdegeliia MR
    Georgian Med News; 2007; (148-149):29-31. PubMed ID: 17921539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Phosphodiesterase-4 inhibitors: roflumilast].
    Izquierdo Alonso JL
    Rev Clin Esp; 2011 Mar; 211 Suppl 2():22-30. PubMed ID: 21596170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticholinergic bronchodilators.
    Witek TJ
    Respir Care Clin N Am; 1999 Dec; 5(4):521-36. PubMed ID: 10565879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination inhaled bronchodilator therapy in the management of chronic obstructive pulmonary disease.
    Nichols J
    Pharmacotherapy; 2007 Mar; 27(3):447-54. PubMed ID: 17316155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Which bronchodilator in COPD?
    Russell R; Singh D
    Int J Chron Obstruct Pulmon Dis; 2007; 2(2):93-4. PubMed ID: 18046837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.